For FGFR1 amplification, 9 of 17 studies were in lung cancer, 4 studies were in breast cancer, and the other 4 studies were about oral and tongue squamous cell carcinoma, and oral squamous cell carcinoma. This evidence concerns the gene FGFR1 and oral cavity squamous cell carcinoma.